Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 6
2020 4
2021 2
2022 3
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Hopes and failures in front-line ovarian cancer therapy.
Tsibulak I, Zeimet AG, Marth C. Tsibulak I, et al. Crit Rev Oncol Hematol. 2019 Nov;143:14-19. doi: 10.1016/j.critrevonc.2019.08.002. Epub 2019 Aug 14. Crit Rev Oncol Hematol. 2019. PMID: 31449982 Free article. Review.
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.
Colombo N, Gadducci A, Sehouli J, Rulli E, Mäenpää J, Sessa C, Montes A, Ottevanger NB, Berger R, Vergote I, D'Incalci M, Churruca Galaz C, Chekerov R, Nyvang GB, Riniker S, Herbertson R, Fossati R, Barretina-Ginesta MP, Deryal M, Mirza MR, Biagioli E, Iglesias M, Funari G, Romeo M, Tasca G, Pardo B, Tognon G, Rubio-Pérez MJ, DeCensi A, De Giorgi U, Zola P, Benedetti Panici P, Aglietta M, Arcangeli V, Zamagni C, Bologna A, Westermann A, Heinzelmann-Schwarz V, Tsibulak I, Wimberger P, Poveda A; INOVATYON study group. Colombo N, et al. Among authors: tsibulak i. Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9. Br J Cancer. 2023. PMID: 36759720 Free PMC article. Clinical Trial.
Immunotherapy in ovarian cancer: fake news or the real deal?
Marth C, Wieser V, Tsibulak I, Zeimet AG. Marth C, et al. Among authors: tsibulak i. Int J Gynecol Cancer. 2019 Jan;29(1):201-211. doi: 10.1136/ijgc-2018-000011. Int J Gynecol Cancer. 2019. PMID: 30640705 Review.
Enhanced recovery after cesarean section (ERAC): Where are we in Austria?
Hochstätter R, Schütz AM, Taumberger N, Bornemann-Cimenti H, Oppelt P, Fazelnia C, Petricevic L, Tsibulak I, Batiduan LM, Tomasch G, Weiss EC, Tamussino K, Metnitz P, Fluhr H, Schöll W. Hochstätter R, et al. Among authors: tsibulak i. Eur J Obstet Gynecol Reprod Biol. 2023 Jun;285:81-85. doi: 10.1016/j.ejogrb.2023.03.043. Epub 2023 Apr 6. Eur J Obstet Gynecol Reprod Biol. 2023. PMID: 37087834 Free article.
Clinical Impact of RANK Signalling in Ovarian Cancer.
Wieser V, Sprung S, Tsibulak I, Haybaeck J, Hackl H, Fiegl H, Marth C, Zeimet AG. Wieser V, et al. Among authors: tsibulak i. Cancers (Basel). 2019 Jun 8;11(6):791. doi: 10.3390/cancers11060791. Cancers (Basel). 2019. PMID: 31181781 Free PMC article.
Dubious effects of methadone as an "anticancer" drug on ovarian cancer cell-lines and patient-derived tumor-spheroids.
Fiegl H, Hagenbuchner J, Kyvelidou C, Seeber B, Sopper S, Tsibulak I, Wieser V, Reiser E, Roessler J, Huhtinen K, Carpén O, Parson W, Sprung S, Marth C, Ausserlechner MJ, Zeimet AG. Fiegl H, et al. Among authors: tsibulak i. Gynecol Oncol. 2022 Apr;165(1):129-136. doi: 10.1016/j.ygyno.2022.01.008. Epub 2022 Jan 13. Gynecol Oncol. 2022. PMID: 35033381 Free article.
The miR-34 family and its clinical significance in ovarian cancer.
Welponer H, Tsibulak I, Wieser V, Degasper C, Shivalingaiah G, Wenzel S, Sprung S, Marth C, Hackl H, Fiegl H, Zeimet AG. Welponer H, et al. Among authors: tsibulak i. J Cancer. 2020 Jan 13;11(6):1446-1456. doi: 10.7150/jca.33831. eCollection 2020. J Cancer. 2020. PMID: 32047551 Free PMC article.
21 results